Addison Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.5K | Buy |
2,170
+97
| +5% | +$1.5K | 0.01% | 459 |
|
2025
Q1 | $30.8K | Sell |
2,073
-38
| -2% | -$565 | 0.01% | 437 |
|
2024
Q4 | $28K | Sell |
2,111
-12,497
| -86% | -$165K | 0.01% | 460 |
|
2024
Q3 | $208K | Buy |
14,608
+13,091
| +863% | +$186K | 0.06% | 206 |
|
2024
Q2 | $19.6K | Buy |
+1,517
| New | +$19.6K | 0.01% | 490 |
|
2024
Q1 | – | Sell |
-496
| Closed | -$7.08K | – | 738 |
|
2023
Q4 | $7.08K | Buy |
+496
| New | +$7.08K | ﹤0.01% | 551 |
|
2022
Q3 | – | Sell |
-3,580
| Closed | -$50K | – | 767 |
|
2022
Q2 | $50K | Buy |
3,580
+250
| +8% | +$3.49K | 0.03% | 263 |
|
2022
Q1 | $48K | Buy |
+3,330
| New | +$48K | 0.03% | 295 |
|